Status:

ACTIVE_NOT_RECRUITING

Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Community Based Study

Cardiovascular Disease

Eligibility:

All Genders

50-75 years

Brief Summary

The aim of the present Paris Prospective Study III (PPS3) is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physio...

Detailed Description

Overall, 10 157 men and women have been recruited during May 2008 and June 2012 for an extensive clinical examination including a 2h holter electrocardiography (ECG), a carotid doppler echo tracking, ...

Eligibility Criteria

Inclusion

  • 50-75 years, French speaking, given consent for genetic analysis,
  • written consent for participating in the study

Exclusion

  • \<50 years and \>75 years,
  • no French speaking,
  • current pregnancy,
  • chronic severe disease,
  • disagreement for genetic analysis,
  • step test considered as non possible or non advisable by medical decision.

Key Trial Info

Start Date :

May 13 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2032

Estimated Enrollment :

10157 Patients enrolled

Trial Details

Trial ID

NCT00741728

Start Date

May 13 2008

End Date

December 1 2032

Last Update

February 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Investigations Pré cliniques et Preventives de Paris

Paris, France, 75016